Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham is a clinical research site located in Birmingham, Alabama, United States 35294.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham has participated in 8 clinical trials.
Therapeutic areas: Glioblastoma Multiforme, Lymphoma, Brain Tumors.
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Children's Oncology Group, Abramson Cancer Center at Penn Medicine.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham has 8 clinical trials on record. Their work covers Glioblastoma Multiforme, Lymphoma, Brain Tumors.
Yes — Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.